factual

Nine-Month FDA Delay for Manufacturing

Spark delayed its FDA approval request by nine months to finish its manufacturing process, drawing criticism, but the result was the first approved facility of any type making a viral-vector-based drug, located at 38th and Market Street in Philadelphia.

factualpending

Speaker

Jeff

Evidence Quote

“in addition to getting the first approved, we ultimately got the first approved facility of any type that was making a viral vector-based drug.”

Source

Compounding For A Cure— Joys of Compounding
Created: 11/11/2026, 6:53:25 PM

Your notes

Loading notes...